Sign On
  • KeyNavigator
    Sign On Form is Loading
  • CIS Online Brokerage CIS Login

Join Managing Directors from Cain Brothers, as they discuss the return of elective procedures as the economy re-opens from the COVID-19 pandemic.

David MorlockCain Brothers Experience

David Morlock is a senior banker in the Firm’s Health Systems M&A Group. Mr. Morlock joined Cain Brothers in 2016 with 30 years of experience as a health system executive. His track record includes strategy development, mergers and acquisitions, affiliation agreements, joint ventures, major capital investments, and other unique arrangements tailored to meet the needs of healthcare organizations’ specific circumstances. Notable and innovative transactions and advisory engagements include the divestiture of MDwise health plan by Indiana University Health, acquisition of Ohio Valley Health by Alecto, affiliation between Fairview Health and the University of Minnesota, healthcare strategic advisory work for the University of North Carolina, affiliation between ProMedica and the University of Toledo College of Medicine, the University of Michigan Health System sale of M-Care to Blue Cross Blue Shield of Michigan, and the University of Michigan’s acquisition of a major research campus from Pfizer. Mr. Morlock is a frequent author of articles and speaker on health care industry mergers and acquisitions and strategic capital insights.

Prior Experience

Prior to joining Cain Brothers, Mr. Morlock was the CEO of the University of Toledo Medical Center, where he had executive responsibility for all aspects of the medical center’s strategy and operations. In addition, Mr. Morlock was CFO of the University of Michigan Health System, with executive responsibility for the financial affairs of the hospitals, clinics, physician group, and medical school. Mr. Morlock was also a Senior Vice President of Accretive Health, where he was responsible for major client executive relationships and business development.

Education

Mr. Morlock earned an MBA from Eastern Michigan University’s Owen School of Business and is an honors graduate of Slippery Rock University.

Wyatt RitchieCain Brothers Experience

Wyatt Ritchie is a senior banker focusing on Post-Acute Care and Outsourced Services.  Mr. Ritchie joined Cain Brothers in 2010 with 23 years’ experience advising both public and private companies in a variety of merger and acquisition, capital raising, and strategic advisory transactions.  Mr. Ritchie’s recent transactions include the refinancing of senior and subordinated debt for American Surgical Professionals, the sale of Centerre Healthcare to Kindred Healthcare, the sale of Specialty Hospitals of Washington, the recapitalization of Results Physiotherapy by Sterling Partners, and Erickson Living’s acquisition of Devonshire at PGA. He is a member of the Firm’s President’s Advisory Council.

Prior Experience

Prior to joining Cain Brothers, Mr. Ritchie was at Jefferies & Company, responsible for that firm’s healthcare services practice. Prior to joining Jefferies, Mr. Ritchie was at CIBC Oppenheimer for eight years where he was responsible for that firm’s West Coast healthcare services investment banking practice and at Bank of America, where he was responsible for Bank of America’s healthcare leverage finance business.

Education

Mr. Ritchie earned BA in Economics from St. Olaf College and an MBA in Finance from the University of Chicago.

John SodenCain Brothers Experience

John Soden co-leads Cain Brothers’ Medical Technologies Advisory practice based in San Francisco. His practice has focused on medical devices, diagnostics and life science tools/reagents since 2001, prior to which he specialized in M&A and worked across multiple industries.

Mr. Soden joined Cain Brothers in early 2016 with over 20 years of investment banking experience, primarily focused on private and public company M&A.  Recent advisory transactions include the sale of SeraCare Life Sciences (owned by Linden) to LGC (owned by KKR), California Cryobank’s sale to GI Partners and its simultaneous merger with Cord Blood Registry, Patricia Industries’ acquisition of Sarnova from Water Street, 3i Group’s acquisition of Cirtec Medical, Frazier’s merger of PREZIO and Northfield, and the sale of Clinical Innovations by The Pritzker Group to EQT Partners. Recent leveraged finance experience includes serving as left lead arranger/joint bookrunner/administrative agent for Linden’s $325mm acquisition financing of Avalign Technologies and as joint bookrunner/joint lead arranger for THL’s SPAC’s $810mm acquisition financing of UHS (renamed Agiliti Health).

Prior Experience

Previously, Mr. Soden was a Managing Director & Head of Medical Technologies at Houlihan Lokey for approximately seven years.  Mr. Soden’s transactions immediately prior to joining Cain Brothers included the sale of Hygiena to Warburg Pincus, Galil Medical to BTG Plc, CORPAK MedSystems (owned by Linden) to Halyard Health, Cord Blood Registry (owned by GTCR) to AMAG Pharmaceuticals, Ivera Medical to 3M, Integrated Medical Systems (IMS) to Steris, and Angiotech’s Interventional business to Argon Medical Devices (then owned by RoundTable Healthcare Partners).  Notable restructuring experience included creditor representations with respect to Ameritox and Angiotech Pharmaceuticals.

Before Houlihan Lokey, Mr. Soden worked for over six years in the Healthcare Group at Thomas Weisel Partners, most recently as a Managing Director, and for five years at UBS (and its predecessor Dillion, Read & Co.), eventually serving as a Director in both the M&A and Healthcare groups. He began his investment banking career as a financial analyst at CS First Boston in 1994.

Education

Mr. Soden received a B.A. in Economics (with Honors) from Northwestern University.

Jamie KingCain Brothers Experience

Jamie King is a senior banker in the Firm’s Health Systems M&A Group and leads Cain Brothers’ Ambulatory Surgery Centers Advisory practice. Mr. King joined Cain Brothers in 2005 and has over 19 years’ experience advising on an array of transactions including sales, acquisitions, mergers, joint ventures, nonprofit conversions, valuations, restructurings, divestitures, recapitalizations, and private placements of debt and equity. Mr. King’s notable transactions include the financing and acquisition of HCA’s interest in OU Medical System by OU Medicine, the divestiture of Saltzer Medical Group from St. Luke’s Health System, the sale of Blue Chip Surgical Center Partners, the sale of Health Inventures to Surgical Care Affiliates, the investment by Irving Place Capital in National Surgical Healthcare, the sale of the American Institute of Gastric Banding to USPI, the merger of Sun Health into Banner Health, and the recapitalization and acquisition by HealthCare Partners of JSA Healthcare Corporation.

Prior Experience

Prior to joining Cain Brothers, Mr. King was at Sorenson Capital, a middle market private equity firm focused on leveraged buyouts and growth equity investments in small and middle market companies across various industries, including healthcare, distribution, and services. Prior to Sorenson Capital, Mr. King was at Lehman Brothers in that firm’s Global Healthcare Group, where he focused on supporting M&A advisory and public equity and debt capital transactions for clients in the healthcare services and medical technology sectors.

Education

Mr. King earned a BS in Finance from Brigham Young University.

Cain Brothers logo